Merck & Co., Inc.
MRK
$125.78
$0.550.44%
| 12/31/2023 | 09/30/2023 | 06/30/2023 | 03/31/2023 | 12/31/2022 | |
|---|---|---|---|---|---|
| Net Income | -1.23B | 4.75B | -5.98B | 2.82B | 3.02B |
| Total Depreciation and Amortization | 903.00M | 978.00M | 881.00M | 970.00M | 869.00M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 425.00M | -183.00M | 10.43B | 438.00M | 891.00M |
| Change in Net Operating Assets | 144.00M | 2.18B | -1.64B | -2.89B | -347.00M |
| Cash from Operations | 246.00M | 7.72B | 3.70B | 1.34B | 4.43B |
| Capital Expenditure | -989.00M | -902.00M | -965.00M | -1.01B | -1.15B |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | 0.00 | 0.00 | -10.71B | -1.33B | 0.00 |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 1.04B | 568.00M | 227.00M | -25.00M | -599.00M |
| Cash from Investing | 53.00M | -334.00M | -11.44B | -2.36B | -1.75B |
| Total Debt Issued | 0.00 | -1.94B | 7.88B | -- | -- |
| Total Debt Repaid | -3.00M | -1.00M | -1.75B | -1.00M | -1.00M |
| Issuance of Common Stock | 6.00M | 7.00M | 82.00M | 30.00M | 265.00M |
| Repurchase of Common Stock | -393.00M | -466.00M | -338.00M | -149.00M | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -1.85B | -1.86B | -1.89B | -1.85B | -1.75B |
| Other Financing Activities | -3.00M | -10.00M | -234.00M | -81.00M | -68.00M |
| Cash from Financing | -2.25B | -4.27B | 3.76B | -2.05B | -1.55B |
| Foreign Exchange rate Adjustments | 186.00M | -157.00M | -93.00M | 87.00M | 366.00M |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -1.76B | 2.96B | -4.07B | -2.99B | 1.49B |
